Resultados de procura

Multicolor-FICTION por José I. Martı́n-Subero, Ilse Chudoba, Lana Harder, Stefan Gesk, W. Grote, Francisco J. Novo, Marı́a José Calasanz, Reiner Siebert

Ligazón do recurso Ligazón do recurso

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphoma por Daruka Mahadevan, Joseph M. Unger, Catherine Spier, Daniel O. Persky, Fay Young, Michael LeBlanc, Richard I. Fisher, Thomas P. Miller

Ligazón do recurso Ligazón do recurso

Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK por Marius Grzelinski, Florian Steinberg, Tobias Martens, Frank Czubayko, Katrin Lamszus, Achim Aigner

Ligazón do recurso

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome por Hervé Tilly, Philippe Gaulard, Éric Lepage, Charles Dumontet, J Diébold, Isabelle Plantier, Françoise Berger, Michel Symann, Tony Petrella, P Lederlin, Josette Brière

Ligazón do recurso Ligazón do recurso

A novel <i>KIF5B‐ALK</i> variant in nonsmall cell lung cancer por Daisy Wing‐Sze Wong, Elaine Lai‐Han Leung, Sunny Kit‐Man Wong, Vicky Pui‐Chi Tin, Alan Dart‐Loon Sihoe, Lik‐Cheung Cheng, Joseph S. K. Au, Lap‐Ping Chung, Maria Pik Wong

Ligazón do recurso Ligazón do recurso

A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation por Georges Delsol, Laurence Lamant, Bernard Mariamé, Karen Pulford, Nicole Dastugue, Pierre Brousset, Françoise Rigal‐Huguet, Talal Al Saati, Douglas Pat Cerretti, Stephan W. Morris, David Y. Mason

Ligazón do recurso Ligazón do recurso

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models por Helen Y. Zou, Luc Friboulet, David P. Kodack, Lars D. Engstrom, Qiuhua Li, Melissa West, Ruth W. Tang, Hui Wang, Konstantinos Tsaparikos, Jinwei Wang, Sergei Timofeevski, Ryohei Katayama, Dac M. Dinh, Hieu Lam, Justine L. Lam, Shinji Yamazaki, Wenyue Hu, Bhushankumar Patel, Divya Bezwada, Rosa L. Frias, Eugene Lifshits, Sidra Mahmood, Justin F. Gainor, Timothy Affolter, Patrick B. Lappin, Hovhannes J. Gukasyan, Nathan Lee, Shibing Deng, Rakesh K. Jain, Ted W. Johnson, Alice T. Shaw, Valeria R. Fantin, Tod Smeal

Ligazón do recurso Ligazón do recurso

Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer por Andrew Weickhardt, Micol S. Rothman, Smita Salian‐Mehta, Katja Kiseljak‐Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

Ligazón do recurso Ligazón do recurso

Heart rate decrease during crizotinib treatment and potential correlation to clinical response por Sai‐Hong Ignatius Ou, Wilson P. Tong, Michele C. Azada, Christina T. Siwak-Tapp, Joni Dy, Jonathan A. Stiber

Ligazón do recurso Ligazón do recurso

Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice por Martin U. Kuefer, A. Thomas Look, Karen Pulford, Frederick G. Behm, Paul K. Pattengale, David Y. Mason, Stephan W. Morris

Ligazón do recurso Ligazón do recurso

The use of stained cytologic direct smears for <i>ALK</i> gene rearrangement analysis of lung adenocarcinoma por Bryan L. Betz, Catherine A. Dixon, Helmut C. Weigelin, Stewart M. Knoepp, Michael H. Roh

Ligazón do recurso Ligazón do recurso

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options por Conor Steuer, Suresh S. Ramalingam

Ligazón do recurso Ligazón do recurso

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer por Jun Ho Ji, Young Lyun Oh, Min Eui Hong, Jae Won Yun, Hyunwoo Lee, Kim DeokGeun, Yongick Ji, Kim Duk-Hwan, Woong‐Yang Park, Hyun‐Tae Shin, Kyoung‐Mee Kim, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

Ligazón do recurso Ligazón do recurso

Identification of anaplastic lymphoma kinase fusions in renal cancer por Emiko Sugawara, Yuki Togashi, Naoto Kuroda, Seiji Sakata, Satoko Hatano, Reimi Asaka, Takeshi Yuasa, Junji Yonese, Masanobu Kitagawa, Hiroyuki Mano, Yuichi Ishikawa, Kengo Takeuchi

Ligazón do recurso Ligazón do recurso

Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1 por Karen Pulford, Laurence Lamant, Stephan W. Morris, Lisa H. Butler, Katrina Wood, David A. Stroud, Georges Delsol, David Y. Mason

Ligazón do recurso

Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data por Gouji Toyokawa, Takashi Seto

Ligazón do recurso Ligazón do recurso

ALK-rearrangements and testing methods in non-small cell lung cancer: a review por Rodney E. Shackelford, Moiz Vora, Kim Mayhall, James D. Cotelingam

Ligazón do recurso Ligazón do recurso

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or l... por AH Sarris, R. Luthra, V. Papadimitracopoulou, M. Waasdorp, Meletios Α. Dimopoulos, J. A. McBride, Fernando Cabanillas, Madeleine Duvic, AB Deisseroth, SW Morris, WC Pugh

Ligazón do recurso Ligazón do recurso

Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer por Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

Ligazón do recurso

STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harbo... por Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, Ralph Zinner, Elvio G. Silva, Julia A. Elvin, Ishwaria M. Subbiah, Chimela Ohaji, Dhakshina Moorthy Ganeshan, Deepa Anand, Charles F. Levenback, Jenny Berry, Timothy J. Brennan, Juliann Chmielecki, Zachary R. Chalmers, John D. Mayfield, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali

Ligazón do recurso Ligazón do recurso